Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis

Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with psoriatic arthritis who developed multisystem sarcoidosis while...

Full description

Saved in:
Bibliographic Details
Published in:BMJ case reports 2021-02, Vol.14 (2), p.e240615
Main Authors: Kirby, Colm, Herlihy, Darragh, Clarke, Lindsey, Mullan, Ronan
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Humanized - adverse effects
Arthritis
Arthritis, Psoriatic - drug therapy
Biopsy
Case Report
Case reports
Cytokines
Disease
Female
Humans
Immunotherapy
Inflammatory diseases
Laboratories
Lymphatic system
Middle Aged
Monoclonal antibodies
Psoriasis
Psoriatic arthritis
Sarcoidosis
Sarcoidosis - chemically induced
Sarcoidosis - diagnosis
Sarcoidosis - drug therapy
Skin
Tumor necrosis factor-TNF
Ultrasonic imaging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b456t-3d6b9916fa9166390830ac90190d20e847941ef67f11c3dab84f5fc3e46d6bdd3
cites cdi_FETCH-LOGICAL-b456t-3d6b9916fa9166390830ac90190d20e847941ef67f11c3dab84f5fc3e46d6bdd3
container_end_page
container_issue 2
container_start_page e240615
container_title BMJ case reports
container_volume 14
creator Kirby, Colm
Herlihy, Darragh
Clarke, Lindsey
Mullan, Ronan
description Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with psoriatic arthritis who developed multisystem sarcoidosis while being treated with secukinumab (anti-interleukin-17A) therapy which, to our knowledge, is the first such case. We discuss existing literature and hypothesise that IL-17 blockade may precipitate the development of granulomatous disease.
doi_str_mv 10.1136/bcr-2020-240615
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7903082</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2492662177</sourcerecordid><originalsourceid>FETCH-LOGICAL-b456t-3d6b9916fa9166390830ac90190d20e847941ef67f11c3dab84f5fc3e46d6bdd3</originalsourceid><addsrcrecordid>eNqFkc9LBCEUxyWKiurcLQa6RDDlU9cZL0FEvyCIqKCbOI62bjvjpk7Rf5_bVlSXPPge-Hlf3tcvQtuADwAoP2x0KAkmuCQMcxgtoXWoRlVZCfyw_KNfQ1sxTnA-FFjN6Cpao5SDAMbX0c2tCtq71kcXi071zpqYXP9YtEOYlxSMSp3pU_Hq0riIRg9Prh861RTWh2IWfXAqOV2okMbBJRc30YpV02i2PusGuj87vTu5KK-uzy9Pjq_Kho14KmnLGyGAW5UvTgWuKVZaYBC4JdjUrBIMjOWVBdC0VU3N7MhqahjPk21LN9DRQnc2NJ1pdd4xqKmcBdep8Ca9cvL3S-_G8tG_yPwnFNckC-x9CgT_PGTbsnNRm-lU9cYPURImCOcEqiqju3_QiR9Cn-19UMAJA5GpwwWlg48xGPu9DGA5T0zmxOQ8MblILE_s_PTwzX_lk4H9BdB0k3_V3gHppqA_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2492162419</pqid></control><display><type>article</type><title>Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis</title><source>PubMed Central</source><creator>Kirby, Colm ; Herlihy, Darragh ; Clarke, Lindsey ; Mullan, Ronan</creator><creatorcontrib>Kirby, Colm ; Herlihy, Darragh ; Clarke, Lindsey ; Mullan, Ronan</creatorcontrib><description>Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with psoriatic arthritis who developed multisystem sarcoidosis while being treated with secukinumab (anti-interleukin-17A) therapy which, to our knowledge, is the first such case. We discuss existing literature and hypothesise that IL-17 blockade may precipitate the development of granulomatous disease.</description><identifier>ISSN: 1757-790X</identifier><identifier>EISSN: 1757-790X</identifier><identifier>DOI: 10.1136/bcr-2020-240615</identifier><identifier>PMID: 33619146</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal, Humanized - adverse effects ; Arthritis ; Arthritis, Psoriatic - drug therapy ; Biopsy ; Case Report ; Case reports ; Cytokines ; Disease ; Female ; Humans ; Immunotherapy ; Inflammatory diseases ; Laboratories ; Lymphatic system ; Middle Aged ; Monoclonal antibodies ; Psoriasis ; Psoriatic arthritis ; Sarcoidosis ; Sarcoidosis - chemically induced ; Sarcoidosis - diagnosis ; Sarcoidosis - drug therapy ; Skin ; Tumor necrosis factor-TNF ; Ultrasonic imaging</subject><ispartof>BMJ case reports, 2021-02, Vol.14 (2), p.e240615</ispartof><rights>BMJ Publishing Group Limited 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2021 BMJ Publishing Group Limited 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>BMJ Publishing Group Limited 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b456t-3d6b9916fa9166390830ac90190d20e847941ef67f11c3dab84f5fc3e46d6bdd3</citedby><cites>FETCH-LOGICAL-b456t-3d6b9916fa9166390830ac90190d20e847941ef67f11c3dab84f5fc3e46d6bdd3</cites><orcidid>0000-0001-7131-6721</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903082/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903082/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33619146$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kirby, Colm</creatorcontrib><creatorcontrib>Herlihy, Darragh</creatorcontrib><creatorcontrib>Clarke, Lindsey</creatorcontrib><creatorcontrib>Mullan, Ronan</creatorcontrib><title>Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis</title><title>BMJ case reports</title><addtitle>BMJ Case Rep</addtitle><description>Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with psoriatic arthritis who developed multisystem sarcoidosis while being treated with secukinumab (anti-interleukin-17A) therapy which, to our knowledge, is the first such case. We discuss existing literature and hypothesise that IL-17 blockade may precipitate the development of granulomatous disease.</description><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal, Humanized - adverse effects</subject><subject>Arthritis</subject><subject>Arthritis, Psoriatic - drug therapy</subject><subject>Biopsy</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Cytokines</subject><subject>Disease</subject><subject>Female</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Inflammatory diseases</subject><subject>Laboratories</subject><subject>Lymphatic system</subject><subject>Middle Aged</subject><subject>Monoclonal antibodies</subject><subject>Psoriasis</subject><subject>Psoriatic arthritis</subject><subject>Sarcoidosis</subject><subject>Sarcoidosis - chemically induced</subject><subject>Sarcoidosis - diagnosis</subject><subject>Sarcoidosis - drug therapy</subject><subject>Skin</subject><subject>Tumor necrosis factor-TNF</subject><subject>Ultrasonic imaging</subject><issn>1757-790X</issn><issn>1757-790X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><recordid>eNqFkc9LBCEUxyWKiurcLQa6RDDlU9cZL0FEvyCIqKCbOI62bjvjpk7Rf5_bVlSXPPge-Hlf3tcvQtuADwAoP2x0KAkmuCQMcxgtoXWoRlVZCfyw_KNfQ1sxTnA-FFjN6Cpao5SDAMbX0c2tCtq71kcXi071zpqYXP9YtEOYlxSMSp3pU_Hq0riIRg9Prh861RTWh2IWfXAqOV2okMbBJRc30YpV02i2PusGuj87vTu5KK-uzy9Pjq_Kho14KmnLGyGAW5UvTgWuKVZaYBC4JdjUrBIMjOWVBdC0VU3N7MhqahjPk21LN9DRQnc2NJ1pdd4xqKmcBdep8Ca9cvL3S-_G8tG_yPwnFNckC-x9CgT_PGTbsnNRm-lU9cYPURImCOcEqiqju3_QiR9Cn-19UMAJA5GpwwWlg48xGPu9DGA5T0zmxOQ8MblILE_s_PTwzX_lk4H9BdB0k3_V3gHppqA_</recordid><startdate>20210222</startdate><enddate>20210222</enddate><creator>Kirby, Colm</creator><creator>Herlihy, Darragh</creator><creator>Clarke, Lindsey</creator><creator>Mullan, Ronan</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7131-6721</orcidid></search><sort><creationdate>20210222</creationdate><title>Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis</title><author>Kirby, Colm ; Herlihy, Darragh ; Clarke, Lindsey ; Mullan, Ronan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b456t-3d6b9916fa9166390830ac90190d20e847941ef67f11c3dab84f5fc3e46d6bdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal, Humanized - adverse effects</topic><topic>Arthritis</topic><topic>Arthritis, Psoriatic - drug therapy</topic><topic>Biopsy</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Cytokines</topic><topic>Disease</topic><topic>Female</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Inflammatory diseases</topic><topic>Laboratories</topic><topic>Lymphatic system</topic><topic>Middle Aged</topic><topic>Monoclonal antibodies</topic><topic>Psoriasis</topic><topic>Psoriatic arthritis</topic><topic>Sarcoidosis</topic><topic>Sarcoidosis - chemically induced</topic><topic>Sarcoidosis - diagnosis</topic><topic>Sarcoidosis - drug therapy</topic><topic>Skin</topic><topic>Tumor necrosis factor-TNF</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kirby, Colm</creatorcontrib><creatorcontrib>Herlihy, Darragh</creatorcontrib><creatorcontrib>Clarke, Lindsey</creatorcontrib><creatorcontrib>Mullan, Ronan</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirby, Colm</au><au>Herlihy, Darragh</au><au>Clarke, Lindsey</au><au>Mullan, Ronan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis</atitle><jtitle>BMJ case reports</jtitle><addtitle>BMJ Case Rep</addtitle><date>2021-02-22</date><risdate>2021</risdate><volume>14</volume><issue>2</issue><spage>e240615</spage><pages>e240615-</pages><issn>1757-790X</issn><eissn>1757-790X</eissn><abstract>Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with psoriatic arthritis who developed multisystem sarcoidosis while being treated with secukinumab (anti-interleukin-17A) therapy which, to our knowledge, is the first such case. We discuss existing literature and hypothesise that IL-17 blockade may precipitate the development of granulomatous disease.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>33619146</pmid><doi>10.1136/bcr-2020-240615</doi><orcidid>https://orcid.org/0000-0001-7131-6721</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1757-790X
ispartof BMJ case reports, 2021-02, Vol.14 (2), p.e240615
issn 1757-790X
1757-790X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7903082
source PubMed Central
subjects Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Humanized - adverse effects
Arthritis
Arthritis, Psoriatic - drug therapy
Biopsy
Case Report
Case reports
Cytokines
Disease
Female
Humans
Immunotherapy
Inflammatory diseases
Laboratories
Lymphatic system
Middle Aged
Monoclonal antibodies
Psoriasis
Psoriatic arthritis
Sarcoidosis
Sarcoidosis - chemically induced
Sarcoidosis - diagnosis
Sarcoidosis - drug therapy
Skin
Tumor necrosis factor-TNF
Ultrasonic imaging
title Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A33%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sarcoidosis%20manifesting%20during%20treatment%20with%20secukinumab%20for%20psoriatic%20arthritis&rft.jtitle=BMJ%20case%20reports&rft.au=Kirby,%20Colm&rft.date=2021-02-22&rft.volume=14&rft.issue=2&rft.spage=e240615&rft.pages=e240615-&rft.issn=1757-790X&rft.eissn=1757-790X&rft_id=info:doi/10.1136/bcr-2020-240615&rft_dat=%3Cproquest_pubme%3E2492662177%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b456t-3d6b9916fa9166390830ac90190d20e847941ef67f11c3dab84f5fc3e46d6bdd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2492162419&rft_id=info:pmid/33619146&rfr_iscdi=true